SCHEMBL24299484

SCHEMBL24299484

N#Cc1ccc(NC2CCC(C(=O)O)CC2)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
DPP4 P27487 3/20 0.48
SLC22A12 Q96S37 3/20 0.43
IDO1 P14902 1/20 0.43
S1PR3 Q99500 1/20 0.41
HTT P42858 2/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
PGR P06401 2/20 0.40
KDR P35968 2/20 0.40
BRAF P15056 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
AR P10275 1/20 0.39
LMNA P02545 2/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24298760 0.90 GRM4 (0.44) HDAC8HDAC6DPP4SLC22A12IDO1
SCHEMBL27169503 0.87 HDAC8 (0.53) HDAC8HDAC6DPP4SLC22A12IDO1
SCHEMBL25905013 0.81 HDAC8 (0.48) HDAC8HDAC6DPP4SLC22A12IDO1
SCHEMBL27236967 0.79 HDAC8 (0.46) HDAC8HDAC6DPP4SLC22A12IDO1
SCHEMBL3326284 0.79 DPP4 (0.49) HDAC8HDAC6DPP4PGRL3MBTL1
SCHEMBL3326291 0.79 DPP4 (0.49) HDAC8HDAC6DPP4PGRL3MBTL1
SCHEMBL3326316 0.79 DPP4 (0.49) HDAC8HDAC6DPP4PGRL3MBTL1
SCHEMBL3125940 0.78 HDAC8 (0.48) HDAC8HDAC6DPP4SLC22A12IDO1
SCHEMBL9984392 0.78 HDAC8 (0.48) HDAC8HDAC6DPP4SLC22A12IDO1
SCHEMBL3025009 0.78 DPP4 (0.50) HDAC8HDAC6DPP4IDO1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022048605-A1 HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, INTERMEDIATE, COMPOSITION, AND APPLICATIONS 南昌奥瑞药业有限公司 2022-03-10 WO disclosed